NPF
ZBH icon

Norris Perne & French’s Zimmer Biomet ZBH Stock Holding History

Norris Perne & French’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,009
Closed -$203K – 174
2014
Q2 		$203K Buy
+2,009
New +$196K 0.04% 165

Other funds holding ZBH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Norris Perne & French's ZBH Position: Q3 2014 in Review

Norris Perne & French sold out of Zimmer Biomet (ZBH) in Q3 2014, closing a stake of 2,009 shares — an estimated $203K sold.

Norris Perne & French first reported a position in ZBH in Q2 2014 and held it in 1 quarter. The position peaked at $203K in Q2 2014. 720 funds tracked by Wall St. Rank hold ZBH as of Q3 2014.

  • Norris Perne & French reported no remaining Zimmer Biomet position as of Q3 2014 after selling out during the quarter.
  • Norris Perne & French sold 2,009 Zimmer Biomet shares in Q3 2014, an estimated $203K.
  • Norris Perne & French first reported a position in Zimmer Biomet in Q2 2014 and held it in 1 quarter.
  • Norris Perne & French's Zimmer Biomet position peaked at $203K in Q2 2014.
  • 720 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2014.

Based on Norris Perne & French's 13F filing for Q3 2014, filed 3 Nov 2014.